LMS Medical founder to present at Annual Conference of the Society of Obstetricians and Gynecologists of Canada

    MONTREAL, June 4 /CNW Telbec/ - LMS Medical Systems (TSX:LMZ), a
healthcare technology company and developer of the CALM(R) patient safety
software systems for obstetrics, today announced that Dr. Emily Hamilton,
Vice-President of Research and Chief Medical Officer of LMS, will be
presenting at the annual conference of the Society of Obstetricians and
Gynecologists of Canada to be held June 25-29 in Calgary, Alberta.
    The two presentations demonstrate the rapid progression from
proof-of-concept to prospective use of CALM Shoulder Screen(TM). This novel
technology has been designed to help clinicians identify which mothers are at
greatest risk for childbirth complicated by shoulder dystocia leading to
permanent weakness or paralysis of the baby's arm. This collaborative work was
conducted with leading US and Canadian centers, demonstrating that the tool
has wide applicability.
    The prospective use study exceeded initial expectations in that the rise
in cesarean sections was much smaller than anticipated. This was accompanied
by the expected downward trend in the rates of shoulder dystocia with
immediate neonatal complications.
    This is a significant advance, as standard guidelines for assessing the
risk of shoulder dystocia apply to only a small minority of today's permanent
injury cases. Counseling mothers based on the current guidelines is difficult
because risk factors, including maternal obesity, are very common. The
personalized probabilities generated using the CALM Shoulder Screen help
mothers and clinicians make informed decisions and balance the increased risks
associated with cesarean against the burden of significant lifetime disability
for the newborn.

    Other Activities-Intention to terminate registration under the US
    Exchange Act of 1934:

    LMS announces its intention to file a Form 15F with the U.S. Securities
and Exchange Commission (the "SEC") to voluntarily terminate the registration
of its Common Shares under the section 12(g) of the United States Securities
Exchange Act of 1934 as amended (the" Exchange Act"). LMS expects the
termination to take effect no later than ninety days after its filing with the
SEC. As a result of filing, the Company will immediately cease to file certain
reports under section 13(a) of the Exchange Act, including annual reports on
Form 20F and reports on Form 6K, with the SEC.
    This action is the result of administrative burden and costs associated
with being a U.S. reporting company, which have increased significantly in the
past years. Overall, LMS believes these burdens and costs outweigh any
benefits derived from the Company's foreign issuer status with the SEC.
    As a TSX-listed reporting issuer, LMS will continue to meet its Canadian
continuous disclosure obligations by filing with the Canadian securities
commissions. LMS shares continue to trade on the TSX under the symbol LMZ. The
Company's filings can be found on the System for Electronic Document Analysis
and Retrieval ("SEDAR") at www.sedar.com.

    About LMS: LMS is a leader in the application of advanced mathematical
modeling and neural networks for medical use. The LMS CALM Decision Support
Suite provides physicians, nursing staff, risk managers and hospital
administrators with clinical information systems and risk management tools
designed to improve outcomes and patient care for mothers and their infants
during childbirth.

    Except for historical information contained herein, the matters discussed
in this news release are forward-looking statements. Because these
forward-looking statements involve risks and uncertainties, there are
important factors that could cause actual results to differ materially from
those expressed implied by the forward-looking statements including, but
without limitation, economic conditions in general and in the healthcare
market, the demand for and market for our products in domestic and
international markets, our current dependence on the CALM product suite, the
challenges associated with developing new products and obtaining regulatory
approvals if necessary, research and development activities, the uncertainty
of acceptance of our products by the medical community, the lengthy sales
cycle for our products, third party reimbursement, competition in our markets,
including the potential introduction of competitive products by others, our
dependence on our distributors, physician training, enforceability and the
costs of enforcement of our patents, potential infringements of our patents
and the other factors set forth from time to time in the Company's filings
with the United States Securities and Exchange Commission and with the
Canadian Securities Commissions. The Company has no intention of or obligation
to update or revise any forward-looking statements, whether as a result of new
information, future events or otherwise.

For further information:

For further information: about LMS Medical Systems: Andrea Miller,
Communications, LMS Medical Systems Inc., (514) 488-3461 Ext. 222, Fax: (514)
488-1880, investor@lmsmedical.com; www.lmsmedical.com; Grant Howard/Dave
Burwell, The Howard Group Inc., Toll Free: 1-888-221-0915,
Info@howardgroupinc.com; www.howardgroupinc.com

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890